In conclusion, our study demonstrated a elevation of CXCL13 in both IBD patients and DSS-induced colitis mice, which contributed to the recruitment of CD4+CXCR5+ T cells to secondary lymphoid organs, thereby promoting the production of regulatory CD5+ B cells. This evidence concerns the gene CD4 and inflammatory bowel disease.